Halog Ointment (Halcinonide Ointment) 0.1 % is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Apply a thin film of 0.1 % Halog Ointment (Halcinonide Ointment) to the affected area two to three times daily.

Occlusive Dressing Technique

Occlusive dressings may be used for the management of psoriasis or other recalcitrant conditions. Apply a thin film of ointment to the lesion, cover with a pliable nonporous film, and seal the edges. If needed additional moisture may be provided by covering the lesion with a dampened clean cotton cloth before the nonporous film is applied or by briefly wetting the affected area with water immediately prior to applying the medication. The frequency of changing dressings is best determined on an individual basis. It may be convenient to apply Halog ointment under an occlusive dressing in the evening and to remove the dressing in the morning (i.e., 12-hour occlusion). When utilizing the 12-hour occlusion regimen, additional ointment should be applied without occlusion, during the day. Reapplication is essential at each dressing change.

If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.

Halog Ointment (Halcinonide Ointment USP) 0.1%:

Tubes containing:

15 g (NDC 0003-1482-15)
30 g (NDC 0003-1482-20)
60 g (NDC 0003-1482-30)

Jars containing:

240 g (NDC 0003-1482-40) of ointment.

Storage

Store at room temperature; avoid excessive heat (104° F).

Westwood-Squibb Pharmaceuticals, Inc.
A Bristol-Myers Squibb Company
Princeton, NJ 08543 USA

Bookmark this page: